E
Expesicor
The startup develops a novel positron emission tomography imaging agent that enables the visualization and objective measurement of pain in patients with neurological disorders. This technology facilitates targeted treatment for conditions such as epilepsy, traumatic brain injury, and neurodegenerative disorders.
Traction –/10
Missoula, United States · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a novel positron emission tomography imaging agent that enables the visualization and objective measurement of pain in patients with neurological disorders. This technology facilitates targeted treatment for conditions such as epilepsy, traumatic brain injury, and neurodegenerative disorders.